highlights on 1l nivolumab chemo for metastatic urothelial carcinoma: the checkmate 901 study
Published 11 months ago • 1.1K plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
2:06
checkmate 901: nivolumab with gemcitabine-cisplatin in urothelial carcinoma
-
1:49
checkmate 901: hrqol findings of nivolumab and gemcitabine-cisplatin in uc
-
2:05
esmo 2020 highlights on nivolumab cabozantinib as 1st line therapy for arcc: the checkmate 9er study
-
2:09
checkmate 032: nivolumab/ipilimumab for urothelial carcinoma
-
1:35
checkmate 274: adjuvant nivolumab versus placebo for urothelial carcinoma
-
3:09
#esmo21 highlights on nivo ipi vs extreme in 1st-line high-risk scchn: the checkmate 651 study
-
5:56
results from checkmate-032, nivolumab and ipilimumab for melanoma
-
4:13
checkmate 214: nivolumab ipilimumab vs sunitinib for advanced or metastatic renal cell carcinoma
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
9:32
checkmate 648: nivolumab plus ipilimumab or nivo plus chemo versus chemo as (1l) treatment for a...
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
4:10
pooled analysis of avelumab for metastatic urothelial carcinoma
-
4:05
checkmate 9la: first-line nivolumab ipilimumab 2 cycles chemotherapy vs 4 cycles chemo in an...
-
8:38
checkmate 459: nivolumab plus chemotherapy for gc / gejc / eac
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
1:45
results from dataset analysis of cdh1-mutated urothelial carcinoma patients
-
3:05
javelin bladder 100: 1l urothelial cancer updates
-
1:33
dr. wolchok on the safety profile in checkmate-067 in melanoma